Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Loans
Loans

SBI Healthcare Opportunities Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : SBI Mutual Fund
  • NAV
    : ₹ 423.2211 0.95%
    (as on 19th December, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 91.81% investment in domestic equities of which 29.63% is in Large Cap stocks, 13.55% is in Mid Cap stocks, 6.93% in Small Cap stocks.The fund has 0.07% investment in Debt, of which 0.07% in Government securities.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 19th December, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 12-Dec-25 9956.70 -0.43% - -0.28% 220/248
1 Month 19-Nov-25 9802.20 -1.98% - -1.25% 227/242
3 Month 19-Sep-25 9654.10 -3.46% - -0.64% 199/237
6 Month 19-Jun-25 10180.00 1.80% - 4.51% 181/227
YTD 01-Jan-25 9662.40 -3.38% - 3.32% 172/213
1 Year 19-Dec-24 9860.60 -1.39% -1.39% 2.01% 151/210
2 Year 19-Dec-23 14040.40 40.40% 18.46% 13.15% 23/159
3 Year 19-Dec-22 19062.60 90.63% 23.97% 17.93% 27/131
5 Year 18-Dec-20 21765.20 117.65% 16.81% 18.24% 61/108
10 Year 18-Dec-15 28653.40 186.53% 11.09% 14.44% 70/76
Since Inception 31-Dec-04 191589.50 1815.89% 15.11% 11.56% 95/251

SIP Returns (NAV as on 19th December, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 19-Dec-24 12000 11990.15 -0.08 % -0.15 %
2 Year 19-Dec-23 24000 26178.43 9.08 % 8.58 %
3 Year 19-Dec-22 36000 46940.04 30.39 % 17.99 %
5 Year 18-Dec-20 60000 94434 57.39 % 18.18 %
10 Year 18-Dec-15 120000 292597 143.83 % 16.97 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Nov,2025)

Portfolio Turnover Ratio : 11.00%  |   Category average turnover ratio is 167.64%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 91.81% | F&O Holdings : 0.00%| Foreign Equity Holdings : 4.01%| Total : 95.82%
No of Stocks : 31 (Category Avg - 44.43) | Large Cap Investments : 29.63%| Mid Cap Investments : 13.55% | Small Cap Investments : 6.93% | Other : 45.71%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 4945.3 11.97% 0.79% 13.98% (Apr 2025) 10.86% (Aug 2025) 27.00 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 2849.9 6.90% -0.36% 7.78% (Jun 2025) 6% (Mar 2025) 4.40 L 0.00
Max Healthcare Institute Ltd. Hospital 2325.6 5.63% 0.01% 6.96% (Jun 2025) 5.62% (Oct 2025) 20.00 L 0.00
Cipla Ltd. Pharmaceuticals 1837.6 4.45% 0.04% 5.9% (Dec 2024) 4.41% (Oct 2025) 12.00 L 0.00
Lupin Ltd. Pharmaceuticals 1749.1 4.23% 0.19% 5.19% (Dec 2024) 4.02% (Aug 2025) 8.40 L 0.00
Lonza Group AG Foreign equity 1655.2 4.01% -0.04% 5% (Feb 2025) 4.01% (Nov 2025) 2.70 L 0.00
Ami Organics Ltd. Pharmaceuticals 1653.8 4.00% 0.19% 4% (Nov 2025) 2.97% (Jun 2025) 9.00 L 0.00
Torrent Pharmaceuticals Ltd. Pharmaceuticals 1488.2 3.60% 0.11% 3.66% (Sep 2025) 2.58% (May 2025) 4.00 L 0.00
Laurus Labs Ltd. Pharmaceuticals 1443.9 3.50% 0.23% 3.5% (Nov 2025) 1.99% (Dec 2024) 14.00 L 0.00
Fortis Healthcare Ltd. Hospital 1378.7 3.34% -0.42% 3.76% (Oct 2025) 2.98% (Dec 2024) 15.00 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
No of Debt Holding 1 (Category Avg - 0.93) | Modified Duration 0.00 Years (Category Avg - 0.00)| Yield to Maturity - -- (Category Avg - 0.00%)

Type of Holdings

Security Type
% Weight
Category Average
GOI 0.00% 0.02%
T-Bills 0.07% 0.44%

Investment / Portfolio Grades

Security Type
% Weight
Category Average
Government Backed 0.07% 0.46%
Low Risk 0.00% 0.00%
Moderate Risk 0.00% 0.00%
High Risk 0.00% 0.00%
Very High Risk 0.00% 0.00%
Others 0.00% 0.00%
Name Type of Instrument Weight (%)
TREPS TREPS 4.30%
Net Receivables Net Receivables -0.19%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 28th November, 2025)

  • Standard Deviation

    Low volatility
    10.94vs12.5
    Category Avg
  • Beta

    Low volatility
    0.83vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.52vs0.98
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.2vs0.16
    Category Avg
  • Jensen's Alpha

    Poor risk adjusted returns
    2.56vs3.49
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 423.45 7.28 5.88 39.95 46.75 36.48
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 273.54 4.34 2.37 15.27 34.24 15.68
Quant BFSI Fund - Regular Plan - Growth NA 728.97 0.37 5.87 13.25 23.18 0.00
Franklin Asian Equity Fund - Growth NA 297.29 2.28 2.92 14.46 22.07 11.14
Nippon India Japan Equity Fund - Growth NA 289.88 2.64 0.80 12.15 21.25 14.82
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1747.87 -0.30 -2.10 17.51 20.64 0.00
SBI Automotive Opportunities Fund - Regular Plan - Growth NA 5379.86 2.36 3.71 17.67 20.51 0.00
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1582.52 1.28 5.14 6.25 20.39 0.00
UTI Transportation and Logistics Fund - Growth NA 4067.49 0.17 -0.66 14.40 20.05 25.82
ICICI Prudential Transportation And Logistics Fund - Regular Plan - Growth NA 3072.52 1.30 0.33 15.31 19.26 29.44

More Funds from SBI Mutual Fund

Out of 139 mutual fund schemes offered by this AMC, 4 is/are ranked 5 * , 7 is/are ranked 4 * , 9 is/are ranked 3 * , 8 is/are ranked 2 * , 10 is/are ranked 1 * , and 101 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
SBI Nifty 50 ETF 4 217587.33 -0.33 2.66 5.42 9.70 13.34
SBI Nifty 50 ETF 4 217587.33 -0.33 2.66 5.42 9.70 13.34
SBI BSE Sensex ETF 5 126145.80 -0.31 2.94 5.04 8.42 12.48
SBI BSE Sensex ETF 5 126145.80 -0.31 2.94 5.04 8.42 12.48
SBI Equity Hybrid Fund - Regular Plan - Growth 4 82958.16 -0.51 1.68 4.07 11.10 14.00
SBI Liquid Fund - Regular Plan - Growth 3 69047.58 0.45 1.40 2.83 6.45 6.88
SBI Large Cap Fund - Regular Plan - Growth 3 55636.63 0.41 1.81 5.16 7.42 13.89
SBI Contra Fund - Regular Plan - Growth 3 49837.52 -0.81 1.52 4.26 2.89 18.93
SBI Focused Fund - Regular Plan - Growth 4 42773.28 0.35 4.00 9.25 13.19 17.65
SBI Arbitrage Opportunities Fund - Regular Plan - Growth 4 41082.90 0.41 1.49 2.80 6.53 7.23
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347